Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. - Wikidata - awgldk - TriplyDB

Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure.

Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure.

http://www.wikidata.org/entity/Q43615416

about

Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis.Optimization of cardiac metabolism in heart failure Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure Noninvasive Detection of Early Metabolic Left Ventricular Remodeling in Systemic Hypertension.Quantitative PET imaging detects early metabolic remodeling in a mouse model of pressure-overload left ventricular hypertrophy in vivo Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation.A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction.Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.Synthesis and evaluation of 15-(4-(2-[¹⁸F]Fluoroethoxy)phenyl)pentadecanoic acid: a potential PET tracer for studying myocardial fatty acid metabolism.Modulating fatty acid oxidation in heart failure.Glucose metabolism and cardiac hypertrophy Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.Persistent overexpression of phosphoglycerate mutase, a glycolytic enzyme, modifies energy metabolism and reduces stress resistance of heart in mice Cardiovascular remodelling in coronary artery disease and heart failure.Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease.Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart.Effects of glucose-insulin-potassium infusion on chronic ischaemic left ventricular dysfunction.Mitochondrial energy metabolism in heart failure: a question of balance.Metabolic modulation of myocardial ischemia.Structure dependence of long-chain [18F]fluorothia fatty acids as myocardial fatty acid oxidation probes.Modification of myocardial substrate use as a therapy for heart failure.The Failing Heart Relies on Ketone Bodies as a Fuel.Mitochondrial protein hyperacetylation in the failing heart Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failure.Metabolic imaging using PET.Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.Genome-wide approach to identify novel candidate genes for beta blocker response in heart failure using an experimental model.New directions in the treatment of heart failure: targeting free fatty acid oxidation.A "PET" area of interest: myocardial metabolism in human systolic heart failure.Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction Intracellular and extracellular targets of molecular imaging in the myocardium.Imaging myocardial metabolism and ischemic memory.Substrate utilization by the failing human heart by direct quantification using arterio-venous blood sampling.Radionuclide noninvasive evaluation of heart failure beyond left ventricular function assessment.Taking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy.β-Adrenergic Receptor and Insulin Resistance in the Heart.Nuclear cardiology and heart failure.Clinical Review: Is the perioperative use of beta-blockers still recommended? A critical review of recent controversies.Potential of metabolic agents as adjunct therapies in heart failure.

P2860

Q24632770-96687B34-A25A-48DE-9708-21BE2B98A727 Q26853332-E99F94AD-8980-45C6-86AF-18CFA1C21C28 Q27023021-D50AEEFB-4515-4070-8640-50B9BC8AD080 Q28177421-1307C3B0-03B6-40B9-A95D-399BA73A05EF Q30278045-D692B070-03C8-40C9-B79D-B212FA8BFDA7 Q30418046-7618FFB8-BACE-49EA-9FF3-C174FDB829DA Q33758755-13E12E66-6CB9-4DFC-9A79-4A44B670231A Q33967758-25C125E6-DFD0-4C29-B6A0-41A1F3962281 Q34361776-549A7D8D-3C31-4F9B-87B4-E3A328421507 Q34700405-B26E7141-159A-4048-B6B2-4D53A79AC1D8 Q34808505-864599E3-BDD7-41C9-968C-2FE3B177E316 Q34808553-629C6208-2DDA-4594-AF23-254FA6A0C505 Q34892203-569D4363-5C4C-47CE-A780-E306EE668491 Q34951279-D48AE088-9495-42F4-ACC6-E031E1278BC5 Q35090566-6F29ACA1-5B04-4228-8E1F-20F44CEC9715 Q35298233-CD589D96-56B8-4672-863E-77DD20FDBF88 Q35574160-077CDABD-E29A-4701-AB2B-00709A27BA07 Q35580699-4396E820-91A4-4419-B7F3-44BAFFFB04C4 Q36070074-50A16B3A-BFF7-4471-9CFF-F6CFD2B27378 Q36416511-70126CA9-A003-4577-920D-D8086742E34F Q36497055-9BEBD864-DD90-45A3-B892-5D2270DF5C9C Q36577562-8337EB52-3D94-426F-A469-0429A3FBA6F1 Q36614537-9CFABAA3-EE47-49F1-85D4-B0130A333671 Q36697686-C3920278-6D61-4F6E-8791-EE5A92E49A9D Q36774157-673CBE03-A64A-4018-83EB-494BCE8CFBFD Q36814420-A1F5DB76-C833-430A-B899-CB7C81C2198B Q36982731-45986DBF-D858-4356-930C-75FCDC70E44B Q37051265-08BD4895-8E78-4C12-BCF2-58C13C567F3C Q37067669-BD2789C4-8E65-491A-9B20-750C26DBA052 Q37086847-E3D0CFA1-9724-487B-AF0E-5D1650470F44 Q37145670-21498DDB-270D-4A47-BDDC-745D655EA1F3 Q37222177-E615A95B-5F7E-4E60-8674-942CAD682416 Q37222180-29AB0D96-843A-4DC0-82E6-8863366DD370 Q37383063-E9D8F767-ED99-4158-B321-1DE1DEE8287A Q37402505-4FD7DFB0-ECCF-45DA-AA7D-A535ECCEE4C6 Q37457580-98ED340A-9DC2-4C22-935B-289CDA258D3F Q37551918-93F088D2-E633-406E-AE37-43E888D9B54E Q37578330-EE46DF1C-41E0-4742-9ABD-E2C689BCDB25 Q37592881-02FE041B-BE4C-43B1-AF65-9FDF062A9B8A Q37608595-FDFD926A-A0D4-4EE0-B511-559725A74229

P2860

Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure.

http://www.wikidata.org/entity/Q43615416

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Myocardial free fatty acid and ...... with congestive heart failure.

@en

Myocardial free fatty acid and ...... with congestive heart failure.

@nl

type

label

Myocardial free fatty acid and ...... with congestive heart failure.

@en

Myocardial free fatty acid and ...... with congestive heart failure.

@nl

prefLabel

Myocardial free fatty acid and ...... with congestive heart failure.

@en

Myocardial free fatty acid and ...... with congestive heart failure.

@nl

P1433

Q43615416-781BF6F1-10A8-40A3-A64A-DCD4447B97E7

P1476

Q43615416-9F60C81B-9D3C-4358-A724-88794B63C232

P2093

Q43615416-0756AF99-047A-420B-80F5-644B3AC250C0

Q43615416-19F74FEB-B14A-40D4-AE49-4D9DAEAFFD88

Q43615416-33C843C6-EF60-48AD-94A1-A7168B3C140E

Q43615416-60E3FF04-B9C8-45F0-8343-59A0AC11564A

Q43615416-8BB97DFF-2F61-4A83-8B72-6D81F6116DB6

Q43615416-AB2DA01C-1220-4678-B2D2-4E4C3A601507

Q43615416-D811CE5F-7DD7-4C91-BD40-50CF1B1B58D3

P304

Q43615416-4C8B5C09-E172-4B0A-A4FA-3C0E409E7EB5

P31

Q43615416-2A8FFAB6-3B62-4776-A7F8-F3C382FEB35C

P356

Q43615416-151B4D6F-BC9F-4644-B86D-A0B249A1ACAB

P407

Q43615416-0D48F0E5-0F33-4A5B-B37F-062D27625F3C

P433

Q43615416-46F8C476-4A32-4C21-B920-E35D111F4794

P478

Q43615416-0074E29B-8609-4DE0-B6E0-24507D76D633

P577

Q43615416-77691B0B-7103-4B19-9F12-58B98CB14AD5

P698

Q43615416-E8A4F46F-3FDE-4BD8-8BD1-C3F3FCD8C7B2

P921

Q43615416-2EFD6DEE-2EAF-4EC2-8E3F-5D0F4C09FA13

Q43615416-4E330511-79DF-43EF-B11B-02074094629C

P356

01.CIR.103.20.2441

P1433

P1476

Myocardial free fatty acid and ...... with congestive heart failure.

@en

P2093

C K Stone

http://www.w3.org/2001/XMLSchema#string

D C Russell

http://www.w3.org/2001/XMLSchema#string

M Taylor

http://www.w3.org/2001/XMLSchema#string

P Stanko

http://www.w3.org/2001/XMLSchema#string

R J Nickles

http://www.w3.org/2001/XMLSchema#string

T R DeGrado

http://www.w3.org/2001/XMLSchema#string

T R Wallhaus

http://www.w3.org/2001/XMLSchema#string

P304

2441-2446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.103.20.2441

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2001-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11369683

http://www.w3.org/2001/XMLSchema#string

P921